nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—breast cancer	0.524	1	CbGaD
Cefotetan—ALB—Irinotecan—breast cancer	0.0614	0.402	CbGbCtD
Cefotetan—ALB—Fluorouracil—breast cancer	0.0589	0.386	CbGbCtD
Cefotetan—ALB—Methotrexate—breast cancer	0.0325	0.213	CbGbCtD
Cefotetan—Cefpiramide—ALB—breast cancer	0.000367	0.252	CrCbGaD
Cefotetan—Neutropenia—Docetaxel—breast cancer	0.000352	0.00124	CcSEcCtD
Cefotetan—Aplastic anaemia—Doxorubicin—breast cancer	0.000351	0.00124	CcSEcCtD
Cefotetan—Thrombocytopenia—Thiotepa—breast cancer	0.000351	0.00123	CcSEcCtD
Cefotetan—Pruritus—Chlorambucil—breast cancer	0.000349	0.00123	CcSEcCtD
Cefotetan—Urticaria—Tamoxifen—breast cancer	0.000349	0.00123	CcSEcCtD
Cefotetan—Abdominal pain—Tamoxifen—breast cancer	0.000347	0.00122	CcSEcCtD
Cefotetan—Pancytopenia—Capecitabine—breast cancer	0.000346	0.00122	CcSEcCtD
Cefotetan—Gastrointestinal pain—Goserelin—breast cancer	0.000343	0.00121	CcSEcCtD
Cefotetan—Urticaria—Melphalan—breast cancer	0.000341	0.0012	CcSEcCtD
Cefotetan—Phlebitis—Epirubicin—breast cancer	0.000341	0.0012	CcSEcCtD
Cefotetan—Neutropenia—Capecitabine—breast cancer	0.000341	0.0012	CcSEcCtD
Cefotetan—Leukopenia—Irinotecan—breast cancer	0.00034	0.00119	CcSEcCtD
Cefotetan—Leukopenia—Mitoxantrone—breast cancer	0.00034	0.00119	CcSEcCtD
Cefotetan—Diarrhoea—Chlorambucil—breast cancer	0.000337	0.00119	CcSEcCtD
Cefotetan—Hepatic function abnormal—Epirubicin—breast cancer	0.000336	0.00118	CcSEcCtD
Cefotetan—Erythema multiforme—Paclitaxel—breast cancer	0.000336	0.00118	CcSEcCtD
Cefotetan—Urticaria—Goserelin—breast cancer	0.000333	0.00117	CcSEcCtD
Cefotetan—Hypersensitivity—Vinblastine—breast cancer	0.000333	0.00117	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Docetaxel—breast cancer	0.000333	0.00117	CcSEcCtD
Cefotetan—Abdominal pain—Goserelin—breast cancer	0.000331	0.00117	CcSEcCtD
Cefotetan—Body temperature increased—Goserelin—breast cancer	0.000331	0.00117	CcSEcCtD
Cefotetan—Leukopenia—Gemcitabine—breast cancer	0.000331	0.00116	CcSEcCtD
Cefotetan—Convulsion—Mitoxantrone—breast cancer	0.000329	0.00116	CcSEcCtD
Cefotetan—Leukopenia—Fluorouracil—breast cancer	0.000325	0.00114	CcSEcCtD
Cefotetan—Hypersensitivity—Tamoxifen—breast cancer	0.000323	0.00114	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Capecitabine—breast cancer	0.000322	0.00113	CcSEcCtD
Cefotetan—Cefonicid—ALB—breast cancer	0.00032	0.219	CrCbGaD
Cefotetan—Discomfort—Irinotecan—breast cancer	0.000319	0.00112	CcSEcCtD
Cefotetan—Discomfort—Mitoxantrone—breast cancer	0.000319	0.00112	CcSEcCtD
Cefotetan—Hypersensitivity—Melphalan—breast cancer	0.000317	0.00111	CcSEcCtD
Cefotetan—Phlebitis—Doxorubicin—breast cancer	0.000315	0.00111	CcSEcCtD
Cefotetan—Convulsion—Fluorouracil—breast cancer	0.000315	0.00111	CcSEcCtD
Cefotetan—Vomiting—Chlorambucil—breast cancer	0.000313	0.0011	CcSEcCtD
Cefotetan—Agranulocytosis—Docetaxel—breast cancer	0.000313	0.0011	CcSEcCtD
Cefotetan—Hepatic function abnormal—Doxorubicin—breast cancer	0.000311	0.00109	CcSEcCtD
Cefotetan—Discomfort—Gemcitabine—breast cancer	0.000311	0.00109	CcSEcCtD
Cefotetan—Pruritus—Tamoxifen—breast cancer	0.00031	0.00109	CcSEcCtD
Cefotetan—Anaphylactic shock—Mitoxantrone—breast cancer	0.00031	0.00109	CcSEcCtD
Cefotetan—Anaphylactic shock—Irinotecan—breast cancer	0.00031	0.00109	CcSEcCtD
Cefotetan—Diarrhoea—Vinblastine—breast cancer	0.000309	0.00109	CcSEcCtD
Cefotetan—Hypersensitivity—Goserelin—breast cancer	0.000309	0.00109	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vinorelbine—breast cancer	0.000307	0.00108	CcSEcCtD
Cefotetan—Discomfort—Fluorouracil—breast cancer	0.000306	0.00107	CcSEcCtD
Cefotetan—Pruritus—Melphalan—breast cancer	0.000304	0.00107	CcSEcCtD
Cefotetan—Agranulocytosis—Capecitabine—breast cancer	0.000303	0.00107	CcSEcCtD
Cefotetan—Thrombocytopenia—Mitoxantrone—breast cancer	0.000303	0.00107	CcSEcCtD
Cefotetan—Thrombocytopenia—Irinotecan—breast cancer	0.000303	0.00107	CcSEcCtD
Cefotetan—Haemoglobin—Docetaxel—breast cancer	0.000303	0.00106	CcSEcCtD
Cefotetan—Anaphylactic shock—Gemcitabine—breast cancer	0.000302	0.00106	CcSEcCtD
Cefotetan—Haemorrhage—Docetaxel—breast cancer	0.000301	0.00106	CcSEcCtD
Cefotetan—Diarrhoea—Tamoxifen—breast cancer	0.0003	0.00106	CcSEcCtD
Cefotetan—Urticaria—Vinorelbine—breast cancer	0.000298	0.00105	CcSEcCtD
Cefotetan—Body temperature increased—Vinorelbine—breast cancer	0.000297	0.00104	CcSEcCtD
Cefotetan—Abdominal pain—Vinorelbine—breast cancer	0.000297	0.00104	CcSEcCtD
Cefotetan—Pruritus—Goserelin—breast cancer	0.000297	0.00104	CcSEcCtD
Cefotetan—Anaphylactic shock—Fluorouracil—breast cancer	0.000296	0.00104	CcSEcCtD
Cefotetan—Thrombocytopenia—Gemcitabine—breast cancer	0.000295	0.00104	CcSEcCtD
Cefotetan—Diarrhoea—Melphalan—breast cancer	0.000294	0.00103	CcSEcCtD
Cefotetan—Gastrointestinal pain—Thiotepa—breast cancer	0.000293	0.00103	CcSEcCtD
Cefotetan—Haemoglobin—Capecitabine—breast cancer	0.000293	0.00103	CcSEcCtD
Cefotetan—Nausea—Chlorambucil—breast cancer	0.000293	0.00103	CcSEcCtD
Cefotetan—Haemorrhage—Capecitabine—breast cancer	0.000292	0.00103	CcSEcCtD
Cefotetan—Thrombocytopenia—Fluorouracil—breast cancer	0.00029	0.00102	CcSEcCtD
Cefotetan—Vomiting—Vinblastine—breast cancer	0.000287	0.00101	CcSEcCtD
Cefotetan—Diarrhoea—Goserelin—breast cancer	0.000287	0.00101	CcSEcCtD
Cefotetan—Erythema multiforme—Docetaxel—breast cancer	0.000285	0.001	CcSEcCtD
Cefotetan—Urticaria—Thiotepa—breast cancer	0.000285	0.001	CcSEcCtD
Cefotetan—Body temperature increased—Thiotepa—breast cancer	0.000283	0.000997	CcSEcCtD
Cefotetan—Abdominal pain—Thiotepa—breast cancer	0.000283	0.000997	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Methotrexate—breast cancer	0.000283	0.000994	CcSEcCtD
Cefotetan—Cefmetazole—ALB—breast cancer	0.000282	0.193	CrCbGaD
Cefotetan—Vomiting—Tamoxifen—breast cancer	0.000279	0.000981	CcSEcCtD
Cefotetan—Leukopenia—Paclitaxel—breast cancer	0.000277	0.000974	CcSEcCtD
Cefotetan—Rash—Tamoxifen—breast cancer	0.000277	0.000973	CcSEcCtD
Cefotetan—Hypersensitivity—Vinorelbine—breast cancer	0.000277	0.000973	CcSEcCtD
Cefotetan—Dermatitis—Tamoxifen—breast cancer	0.000276	0.000972	CcSEcCtD
Cefotetan—Erythema multiforme—Capecitabine—breast cancer	0.000276	0.00097	CcSEcCtD
Cefotetan—Vomiting—Melphalan—breast cancer	0.000273	0.000961	CcSEcCtD
Cefotetan—Rash—Melphalan—breast cancer	0.000271	0.000953	CcSEcCtD
Cefotetan—Dermatitis—Melphalan—breast cancer	0.000271	0.000952	CcSEcCtD
Cefotetan—Eosinophilia—Methotrexate—breast cancer	0.000269	0.000945	CcSEcCtD
Cefotetan—Nausea—Vinblastine—breast cancer	0.000268	0.000944	CcSEcCtD
Cefotetan—Convulsion—Paclitaxel—breast cancer	0.000268	0.000943	CcSEcCtD
Cefotetan—Vomiting—Goserelin—breast cancer	0.000266	0.000937	CcSEcCtD
Cefotetan—Pruritus—Vinorelbine—breast cancer	0.000266	0.000934	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.000264	0.00093	CcSEcCtD
Cefotetan—Rash—Goserelin—breast cancer	0.000264	0.000929	CcSEcCtD
Cefotetan—Hypersensitivity—Thiotepa—breast cancer	0.000264	0.000929	CcSEcCtD
Cefotetan—Dermatitis—Goserelin—breast cancer	0.000264	0.000929	CcSEcCtD
Cefotetan—Nausea—Tamoxifen—breast cancer	0.000261	0.000917	CcSEcCtD
Cefotetan—Discomfort—Paclitaxel—breast cancer	0.00026	0.000915	CcSEcCtD
Cefotetan—Pancytopenia—Methotrexate—breast cancer	0.000258	0.000906	CcSEcCtD
Cefotetan—Diarrhoea—Vinorelbine—breast cancer	0.000257	0.000903	CcSEcCtD
Cefotetan—Nausea—Melphalan—breast cancer	0.000255	0.000898	CcSEcCtD
Cefotetan—Neutropenia—Methotrexate—breast cancer	0.000254	0.000892	CcSEcCtD
Cefotetan—Pruritus—Thiotepa—breast cancer	0.000254	0.000892	CcSEcCtD
Cefotetan—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000253	0.00089	CcSEcCtD
Cefotetan—Gastrointestinal pain—Irinotecan—breast cancer	0.000253	0.00089	CcSEcCtD
Cefotetan—Anaphylactic shock—Paclitaxel—breast cancer	0.000252	0.000888	CcSEcCtD
Cefotetan—Eosinophilia—Epirubicin—breast cancer	0.000251	0.000884	CcSEcCtD
Cefotetan—Nausea—Goserelin—breast cancer	0.000249	0.000876	CcSEcCtD
Cefotetan—Thrombocytopenia—Paclitaxel—breast cancer	0.000247	0.000869	CcSEcCtD
Cefotetan—Urticaria—Mitoxantrone—breast cancer	0.000246	0.000865	CcSEcCtD
Cefotetan—Diarrhoea—Thiotepa—breast cancer	0.000245	0.000863	CcSEcCtD
Cefotetan—Abdominal pain—Mitoxantrone—breast cancer	0.000245	0.000861	CcSEcCtD
Cefotetan—Body temperature increased—Irinotecan—breast cancer	0.000245	0.000861	CcSEcCtD
Cefotetan—Body temperature increased—Mitoxantrone—breast cancer	0.000245	0.000861	CcSEcCtD
Cefotetan—Abdominal pain—Irinotecan—breast cancer	0.000245	0.000861	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000245	0.000861	CcSEcCtD
Cefotetan—Pancytopenia—Epirubicin—breast cancer	0.000241	0.000848	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.00024	0.000843	CcSEcCtD
Cefotetan—Vomiting—Vinorelbine—breast cancer	0.000239	0.000839	CcSEcCtD
Cefotetan—Body temperature increased—Gemcitabine—breast cancer	0.000238	0.000838	CcSEcCtD
Cefotetan—Neutropenia—Epirubicin—breast cancer	0.000237	0.000835	CcSEcCtD
Cefotetan—Rash—Vinorelbine—breast cancer	0.000237	0.000832	CcSEcCtD
Cefotetan—Dermatitis—Vinorelbine—breast cancer	0.000236	0.000832	CcSEcCtD
Cefotetan—Urticaria—Fluorouracil—breast cancer	0.000236	0.000828	CcSEcCtD
Cefotetan—Leukopenia—Docetaxel—breast cancer	0.000235	0.000826	CcSEcCtD
Cefotetan—Body temperature increased—Fluorouracil—breast cancer	0.000234	0.000824	CcSEcCtD
Cefotetan—Eosinophilia—Doxorubicin—breast cancer	0.000233	0.000818	CcSEcCtD
Cefotetan—Hypersensitivity—Mitoxantrone—breast cancer	0.000228	0.000802	CcSEcCtD
Cefotetan—Hypersensitivity—Irinotecan—breast cancer	0.000228	0.000802	CcSEcCtD
Cefotetan—Vomiting—Thiotepa—breast cancer	0.000228	0.000802	CcSEcCtD
Cefotetan—Leukopenia—Capecitabine—breast cancer	0.000227	0.000799	CcSEcCtD
Cefotetan—Convulsion—Docetaxel—breast cancer	0.000227	0.000799	CcSEcCtD
Cefotetan—Rash—Thiotepa—breast cancer	0.000226	0.000795	CcSEcCtD
Cefotetan—Dermatitis—Thiotepa—breast cancer	0.000226	0.000794	CcSEcCtD
Cefotetan—Agranulocytosis—Methotrexate—breast cancer	0.000226	0.000794	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000224	0.000789	CcSEcCtD
Cefotetan—Pancytopenia—Doxorubicin—breast cancer	0.000223	0.000784	CcSEcCtD
Cefotetan—Nausea—Vinorelbine—breast cancer	0.000223	0.000784	CcSEcCtD
Cefotetan—Neutropenia—Doxorubicin—breast cancer	0.00022	0.000772	CcSEcCtD
Cefotetan—Hypersensitivity—Fluorouracil—breast cancer	0.000218	0.000768	CcSEcCtD
Cefotetan—Haemoglobin—Methotrexate—breast cancer	0.000218	0.000767	CcSEcCtD
Cefotetan—Haemorrhage—Methotrexate—breast cancer	0.000217	0.000764	CcSEcCtD
Cefotetan—Anaphylactic shock—Docetaxel—breast cancer	0.000214	0.000753	CcSEcCtD
Cefotetan—Discomfort—Capecitabine—breast cancer	0.000214	0.000751	CcSEcCtD
Cefotetan—Pruritus—Gemcitabine—breast cancer	0.000213	0.00075	CcSEcCtD
Cefotetan—Nausea—Thiotepa—breast cancer	0.000213	0.000749	CcSEcCtD
Cefotetan—Diarrhoea—Mitoxantrone—breast cancer	0.000212	0.000745	CcSEcCtD
Cefotetan—Diarrhoea—Irinotecan—breast cancer	0.000212	0.000745	CcSEcCtD
Cefotetan—Agranulocytosis—Epirubicin—breast cancer	0.000211	0.000743	CcSEcCtD
Cefotetan—Pruritus—Fluorouracil—breast cancer	0.00021	0.000738	CcSEcCtD
Cefotetan—Thrombocytopenia—Docetaxel—breast cancer	0.00021	0.000737	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000208	0.00073	CcSEcCtD
Cefotetan—Gastrointestinal pain—Paclitaxel—breast cancer	0.000206	0.000726	CcSEcCtD
Cefotetan—Diarrhoea—Gemcitabine—breast cancer	0.000206	0.000726	CcSEcCtD
Cefotetan—Erythema multiforme—Methotrexate—breast cancer	0.000205	0.000722	CcSEcCtD
Cefotetan—Haemoglobin—Epirubicin—breast cancer	0.000204	0.000718	CcSEcCtD
Cefotetan—Haemorrhage—Epirubicin—breast cancer	0.000203	0.000715	CcSEcCtD
Cefotetan—Diarrhoea—Fluorouracil—breast cancer	0.000203	0.000714	CcSEcCtD
Cefotetan—Thrombocytopenia—Capecitabine—breast cancer	0.000203	0.000713	CcSEcCtD
Cefotetan—Urticaria—Paclitaxel—breast cancer	0.000201	0.000705	CcSEcCtD
Cefotetan—Abdominal pain—Paclitaxel—breast cancer	0.0002	0.000702	CcSEcCtD
Cefotetan—Body temperature increased—Paclitaxel—breast cancer	0.0002	0.000702	CcSEcCtD
Cefotetan—Vomiting—Mitoxantrone—breast cancer	0.000197	0.000692	CcSEcCtD
Cefotetan—Vomiting—Irinotecan—breast cancer	0.000197	0.000692	CcSEcCtD
Cefotetan—Agranulocytosis—Doxorubicin—breast cancer	0.000195	0.000687	CcSEcCtD
Cefotetan—Rash—Mitoxantrone—breast cancer	0.000195	0.000687	CcSEcCtD
Cefotetan—Rash—Irinotecan—breast cancer	0.000195	0.000687	CcSEcCtD
Cefotetan—Dermatitis—Mitoxantrone—breast cancer	0.000195	0.000686	CcSEcCtD
Cefotetan—Dermatitis—Irinotecan—breast cancer	0.000195	0.000686	CcSEcCtD
Cefotetan—Erythema multiforme—Epirubicin—breast cancer	0.000192	0.000676	CcSEcCtD
Cefotetan—Vomiting—Gemcitabine—breast cancer	0.000192	0.000674	CcSEcCtD
Cefotetan—Rash—Gemcitabine—breast cancer	0.00019	0.000669	CcSEcCtD
Cefotetan—Dermatitis—Gemcitabine—breast cancer	0.00019	0.000668	CcSEcCtD
Cefotetan—Haemoglobin—Doxorubicin—breast cancer	0.000189	0.000665	CcSEcCtD
Cefotetan—Vomiting—Fluorouracil—breast cancer	0.000189	0.000663	CcSEcCtD
Cefotetan—Cefoperazone—ALB—breast cancer	0.000189	0.129	CrCbGaD
Cefotetan—Haemorrhage—Doxorubicin—breast cancer	0.000188	0.000661	CcSEcCtD
Cefotetan—Rash—Fluorouracil—breast cancer	0.000187	0.000658	CcSEcCtD
Cefotetan—Dermatitis—Fluorouracil—breast cancer	0.000187	0.000657	CcSEcCtD
Cefotetan—Hypersensitivity—Paclitaxel—breast cancer	0.000186	0.000654	CcSEcCtD
Cefotetan—Nausea—Mitoxantrone—breast cancer	0.000184	0.000647	CcSEcCtD
Cefotetan—Nausea—Irinotecan—breast cancer	0.000184	0.000647	CcSEcCtD
Cefotetan—Nausea—Gemcitabine—breast cancer	0.000179	0.00063	CcSEcCtD
Cefotetan—Pruritus—Paclitaxel—breast cancer	0.000179	0.000628	CcSEcCtD
Cefotetan—Erythema multiforme—Doxorubicin—breast cancer	0.000178	0.000625	CcSEcCtD
Cefotetan—Nausea—Fluorouracil—breast cancer	0.000176	0.000619	CcSEcCtD
Cefotetan—Gastrointestinal pain—Docetaxel—breast cancer	0.000175	0.000615	CcSEcCtD
Cefotetan—Diarrhoea—Paclitaxel—breast cancer	0.000173	0.000608	CcSEcCtD
Cefotetan—Gastrointestinal pain—Capecitabine—breast cancer	0.000169	0.000596	CcSEcCtD
Cefotetan—Body temperature increased—Docetaxel—breast cancer	0.000169	0.000595	CcSEcCtD
Cefotetan—Abdominal pain—Docetaxel—breast cancer	0.000169	0.000595	CcSEcCtD
Cefotetan—Leukopenia—Methotrexate—breast cancer	0.000169	0.000595	CcSEcCtD
Cefotetan—Urticaria—Capecitabine—breast cancer	0.000165	0.000579	CcSEcCtD
Cefotetan—Abdominal pain—Capecitabine—breast cancer	0.000164	0.000576	CcSEcCtD
Cefotetan—Body temperature increased—Capecitabine—breast cancer	0.000164	0.000576	CcSEcCtD
Cefotetan—Convulsion—Methotrexate—breast cancer	0.000164	0.000576	CcSEcCtD
Cefotetan—Vomiting—Paclitaxel—breast cancer	0.000161	0.000565	CcSEcCtD
Cefotetan—Rash—Paclitaxel—breast cancer	0.000159	0.00056	CcSEcCtD
Cefotetan—Dermatitis—Paclitaxel—breast cancer	0.000159	0.000559	CcSEcCtD
Cefotetan—Discomfort—Methotrexate—breast cancer	0.000159	0.000559	CcSEcCtD
Cefotetan—Leukopenia—Epirubicin—breast cancer	0.000158	0.000557	CcSEcCtD
Cefotetan—Hypersensitivity—Docetaxel—breast cancer	0.000158	0.000555	CcSEcCtD
Cefotetan—Cefazolin—ALB—breast cancer	0.000155	0.106	CrCbGaD
Cefotetan—Anaphylactic shock—Methotrexate—breast cancer	0.000154	0.000542	CcSEcCtD
Cefotetan—Convulsion—Epirubicin—breast cancer	0.000153	0.000539	CcSEcCtD
Cefotetan—Hypersensitivity—Capecitabine—breast cancer	0.000153	0.000537	CcSEcCtD
Cefotetan—Pruritus—Docetaxel—breast cancer	0.000151	0.000533	CcSEcCtD
Cefotetan—Thrombocytopenia—Methotrexate—breast cancer	0.000151	0.000531	CcSEcCtD
Cefotetan—Nausea—Paclitaxel—breast cancer	0.00015	0.000527	CcSEcCtD
Cefotetan—Discomfort—Epirubicin—breast cancer	0.000149	0.000523	CcSEcCtD
Cefotetan—Ceftriaxone—ALB—breast cancer	0.000147	0.101	CrCbGaD
Cefotetan—Pruritus—Capecitabine—breast cancer	0.000147	0.000516	CcSEcCtD
Cefotetan—Leukopenia—Doxorubicin—breast cancer	0.000146	0.000515	CcSEcCtD
Cefotetan—Diarrhoea—Docetaxel—breast cancer	0.000146	0.000515	CcSEcCtD
Cefotetan—Anaphylactic shock—Epirubicin—breast cancer	0.000144	0.000508	CcSEcCtD
Cefotetan—Convulsion—Doxorubicin—breast cancer	0.000142	0.000499	CcSEcCtD
Cefotetan—Diarrhoea—Capecitabine—breast cancer	0.000142	0.000499	CcSEcCtD
Cefotetan—Thrombocytopenia—Epirubicin—breast cancer	0.000141	0.000497	CcSEcCtD
Cefotetan—Discomfort—Doxorubicin—breast cancer	0.000138	0.000484	CcSEcCtD
Cefotetan—Vomiting—Docetaxel—breast cancer	0.000136	0.000479	CcSEcCtD
Cefotetan—Rash—Docetaxel—breast cancer	0.000135	0.000475	CcSEcCtD
Cefotetan—Dermatitis—Docetaxel—breast cancer	0.000135	0.000474	CcSEcCtD
Cefotetan—Anaphylactic shock—Doxorubicin—breast cancer	0.000134	0.00047	CcSEcCtD
Cefotetan—Vomiting—Capecitabine—breast cancer	0.000132	0.000463	CcSEcCtD
Cefotetan—Thrombocytopenia—Doxorubicin—breast cancer	0.000131	0.00046	CcSEcCtD
Cefotetan—Rash—Capecitabine—breast cancer	0.000131	0.000459	CcSEcCtD
Cefotetan—Dermatitis—Capecitabine—breast cancer	0.000131	0.000459	CcSEcCtD
Cefotetan—Nausea—Docetaxel—breast cancer	0.000127	0.000447	CcSEcCtD
Cefotetan—Gastrointestinal pain—Methotrexate—breast cancer	0.000126	0.000444	CcSEcCtD
Cefotetan—Nausea—Capecitabine—breast cancer	0.000123	0.000433	CcSEcCtD
Cefotetan—Urticaria—Methotrexate—breast cancer	0.000123	0.000431	CcSEcCtD
Cefotetan—Abdominal pain—Methotrexate—breast cancer	0.000122	0.000429	CcSEcCtD
Cefotetan—Body temperature increased—Methotrexate—breast cancer	0.000122	0.000429	CcSEcCtD
Cefotetan—Gastrointestinal pain—Epirubicin—breast cancer	0.000118	0.000415	CcSEcCtD
Cefotetan—Urticaria—Epirubicin—breast cancer	0.000115	0.000403	CcSEcCtD
Cefotetan—Abdominal pain—Epirubicin—breast cancer	0.000114	0.000401	CcSEcCtD
Cefotetan—Body temperature increased—Epirubicin—breast cancer	0.000114	0.000401	CcSEcCtD
Cefotetan—Hypersensitivity—Methotrexate—breast cancer	0.000114	0.0004	CcSEcCtD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CFL1—breast cancer	0.000112	0.00295	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—MTHFR—breast cancer	0.000111	0.00292	CbGpPWpGaD
Cefotetan—Gastrointestinal pain—Doxorubicin—breast cancer	0.000109	0.000384	CcSEcCtD
Cefotetan—Pruritus—Methotrexate—breast cancer	0.000109	0.000384	CcSEcCtD
Cefotetan—Hypersensitivity—Epirubicin—breast cancer	0.000106	0.000374	CcSEcCtD
Cefotetan—Urticaria—Doxorubicin—breast cancer	0.000106	0.000373	CcSEcCtD
Cefotetan—Body temperature increased—Doxorubicin—breast cancer	0.000106	0.000371	CcSEcCtD
Cefotetan—Abdominal pain—Doxorubicin—breast cancer	0.000106	0.000371	CcSEcCtD
Cefotetan—Diarrhoea—Methotrexate—breast cancer	0.000106	0.000371	CcSEcCtD
Cefotetan—ALB—Platelet degranulation—FN1—breast cancer	0.000105	0.00276	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—VEGFC—breast cancer	0.000105	0.00276	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—ALDOA—breast cancer	0.000105	0.00276	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—RAD51B—breast cancer	0.000105	0.00275	CbGpPWpGaD
Cefotetan—Pruritus—Epirubicin—breast cancer	0.000102	0.000359	CcSEcCtD
Cefotetan—ALB—Folate Metabolism—SERPINE1—breast cancer	0.000102	0.00268	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL1B—breast cancer	0.000102	0.00268	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—FN1—breast cancer	0.0001	0.00263	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—EGF—breast cancer	9.94e-05	0.00261	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—COX11—breast cancer	9.9e-05	0.0026	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC39A7—breast cancer	9.9e-05	0.0026	CbGpPWpGaD
Cefotetan—Diarrhoea—Epirubicin—breast cancer	9.88e-05	0.000347	CcSEcCtD
Cefotetan—Hypersensitivity—Doxorubicin—breast cancer	9.84e-05	0.000346	CcSEcCtD
Cefotetan—Vomiting—Methotrexate—breast cancer	9.81e-05	0.000345	CcSEcCtD
Cefotetan—Rash—Methotrexate—breast cancer	9.72e-05	0.000342	CcSEcCtD
Cefotetan—Dermatitis—Methotrexate—breast cancer	9.72e-05	0.000342	CcSEcCtD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—EGF—breast cancer	9.47e-05	0.00249	CbGpPWpGaD
Cefotetan—Pruritus—Doxorubicin—breast cancer	9.45e-05	0.000332	CcSEcCtD
Cefotetan—ALB—Folate Metabolism—IFNG—breast cancer	9.29e-05	0.00244	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—IGF1—breast cancer	9.2e-05	0.00242	CbGpPWpGaD
Cefotetan—Vomiting—Epirubicin—breast cancer	9.18e-05	0.000323	CcSEcCtD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	9.17e-05	0.00241	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—RELA—breast cancer	9.16e-05	0.00241	CbGpPWpGaD
Cefotetan—Nausea—Methotrexate—breast cancer	9.16e-05	0.000322	CcSEcCtD
Cefotetan—Diarrhoea—Doxorubicin—breast cancer	9.14e-05	0.000321	CcSEcCtD
Cefotetan—Rash—Epirubicin—breast cancer	9.1e-05	0.00032	CcSEcCtD
Cefotetan—Dermatitis—Epirubicin—breast cancer	9.09e-05	0.00032	CcSEcCtD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC22A18—breast cancer	9.06e-05	0.00238	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SERPINB2—breast cancer	8.9e-05	0.00234	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—RAD51C—breast cancer	8.9e-05	0.00234	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC2A2—breast cancer	8.88e-05	0.00234	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TGFB2—breast cancer	8.83e-05	0.00232	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—THBS1—breast cancer	8.79e-05	0.00231	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—breast cancer	8.77e-05	0.00231	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—SERPINE1—breast cancer	8.74e-05	0.0023	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLCO1B1—breast cancer	8.72e-05	0.00229	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC2A5—breast cancer	8.72e-05	0.00229	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PDE2A—breast cancer	8.67e-05	0.00228	CbGpPWpGaD
Cefotetan—Nausea—Epirubicin—breast cancer	8.57e-05	0.000302	CcSEcCtD
Cefotetan—Vomiting—Doxorubicin—breast cancer	8.49e-05	0.000299	CcSEcCtD
Cefotetan—Rash—Doxorubicin—breast cancer	8.42e-05	0.000296	CcSEcCtD
Cefotetan—Dermatitis—Doxorubicin—breast cancer	8.41e-05	0.000296	CcSEcCtD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—breast cancer	8.33e-05	0.00219	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	8.33e-05	0.00219	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	8.33e-05	0.00219	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL1B—breast cancer	8.28e-05	0.00218	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—KDM1A—breast cancer	8.27e-05	0.00217	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL2—breast cancer	8.25e-05	0.00217	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SERPINE1—breast cancer	8.1e-05	0.00213	CbGpPWpGaD
Cefotetan—Nausea—Doxorubicin—breast cancer	7.93e-05	0.000279	CcSEcCtD
Cefotetan—ALB—Hemostasis—STIM1—breast cancer	7.93e-05	0.00208	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HADHB—breast cancer	7.89e-05	0.00208	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC39A6—breast cancer	7.5e-05	0.00197	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—TNF—breast cancer	7.39e-05	0.00194	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IFNG—breast cancer	7.38e-05	0.00194	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—RELA—breast cancer	7.28e-05	0.00191	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—FHL2—breast cancer	7.22e-05	0.0019	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC5A5—breast cancer	7.12e-05	0.00187	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—PTGS2—breast cancer	7.07e-05	0.00186	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PLG—breast cancer	6.98e-05	0.00184	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F3—breast cancer	6.93e-05	0.00182	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC2A1—breast cancer	6.88e-05	0.00181	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ATP7B—breast cancer	6.86e-05	0.0018	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	6.71e-05	0.00176	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PDGFA—breast cancer	6.63e-05	0.00174	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL1B—breast cancer	6.58e-05	0.00173	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	6.5e-05	0.00171	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—ITPR1—breast cancer	6.43e-05	0.00169	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCC1—breast cancer	6.38e-05	0.00168	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	6.19e-05	0.00163	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—VEGFA—breast cancer	6.01e-05	0.00158	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—TNF—breast cancer	6.01e-05	0.00158	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PLA2G4A—breast cancer	6.01e-05	0.00158	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—HGF—breast cancer	6.01e-05	0.00158	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX2—breast cancer	5.98e-05	0.00157	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL6—breast cancer	5.96e-05	0.00157	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CSF2—breast cancer	5.94e-05	0.00156	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX4—breast cancer	5.91e-05	0.00155	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CFL1—breast cancer	5.78e-05	0.00152	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—IDH1—breast cancer	5.77e-05	0.00152	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GRB7—breast cancer	5.73e-05	0.00151	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—breast cancer	5.73e-05	0.00151	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SYNJ2—breast cancer	5.6e-05	0.00147	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—TGFB1—breast cancer	5.52e-05	0.00145	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—TUBB3—breast cancer	5.43e-05	0.00143	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VEGFC—breast cancer	5.41e-05	0.00142	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ALDOA—breast cancer	5.41e-05	0.00142	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—TP53—breast cancer	5.3e-05	0.00139	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—breast cancer	5.26e-05	0.00138	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NDUFS3—breast cancer	5.2e-05	0.00137	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—MED12—breast cancer	5e-05	0.00132	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CHST9—breast cancer	4.89e-05	0.00129	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL6—breast cancer	4.85e-05	0.00128	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	4.78e-05	0.00126	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—TNF—breast cancer	4.77e-05	0.00126	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—FN1—breast cancer	4.66e-05	0.00123	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	4.65e-05	0.00122	CbGpPWpGaD
Cefotetan—ALB—Metabolism—COX11—breast cancer	4.64e-05	0.00122	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	4.56e-05	0.0012	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TGFB2—breast cancer	4.55e-05	0.0012	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—THBS1—breast cancer	4.53e-05	0.00119	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC2A2—breast cancer	4.51e-05	0.00119	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GATA3—breast cancer	4.47e-05	0.00117	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CG—breast cancer	4.46e-05	0.00117	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ACHE—breast cancer	4.42e-05	0.00116	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCG2—breast cancer	4.42e-05	0.00116	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—EGF—breast cancer	4.41e-05	0.00116	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SHMT1—breast cancer	4.24e-05	0.00112	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CDA—breast cancer	4.24e-05	0.00112	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	4.19e-05	0.0011	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	4.15e-05	0.00109	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC2A5—breast cancer	4.08e-05	0.00107	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLCO1B1—breast cancer	4.08e-05	0.00107	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IGF1—breast cancer	4.08e-05	0.00107	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—AKT2—breast cancer	4.08e-05	0.00107	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IFNB1—breast cancer	4.01e-05	0.00105	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.99e-05	0.00105	CbGpPWpGaD
Cefotetan—ALB—Metabolism—APRT—breast cancer	3.94e-05	0.00104	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—TFRC—breast cancer	3.94e-05	0.00104	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CD—breast cancer	3.92e-05	0.00103	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SERPINE1—breast cancer	3.88e-05	0.00102	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.87e-05	0.00102	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.85e-05	0.00101	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL6—breast cancer	3.85e-05	0.00101	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—NCOA2—breast cancer	3.79e-05	0.000998	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ESRRA—breast cancer	3.71e-05	0.000975	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ANGPTL4—breast cancer	3.71e-05	0.000975	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAUR—breast cancer	3.68e-05	0.000969	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.62e-05	0.000952	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLG—breast cancer	3.6e-05	0.000947	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	3.53e-05	0.000927	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPI—breast cancer	3.51e-05	0.000924	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HADHB—breast cancer	3.51e-05	0.000924	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—RAF1—breast cancer	3.5e-05	0.00092	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.5e-05	0.000919	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PDGFA—breast cancer	3.42e-05	0.000899	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CB—breast cancer	3.42e-05	0.000899	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	3.36e-05	0.000884	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALDH1A1—breast cancer	3.35e-05	0.000882	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALDH7A1—breast cancer	3.35e-05	0.000882	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ITPR1—breast cancer	3.31e-05	0.000872	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	3.31e-05	0.000872	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ABL1—breast cancer	3.29e-05	0.000866	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NME1—breast cancer	3.21e-05	0.000845	CbGpPWpGaD
Cefotetan—ALB—Metabolism—FHL2—breast cancer	3.21e-05	0.000845	CbGpPWpGaD
Cefotetan—ALB—Metabolism—UMPS—breast cancer	3.21e-05	0.000845	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ADSL—breast cancer	3.21e-05	0.000845	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PHGDH—breast cancer	3.21e-05	0.000845	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—NCOA1—breast cancer	3.2e-05	0.000841	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HPSE—breast cancer	3.15e-05	0.000829	CbGpPWpGaD
Cefotetan—ALB—Metabolism—BRIP1—breast cancer	3.15e-05	0.000829	CbGpPWpGaD
Cefotetan—ALB—Metabolism—LDHB—breast cancer	3.15e-05	0.000829	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IL2—breast cancer	3.14e-05	0.000825	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—PLG—breast cancer	3.12e-05	0.000819	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLA2G4A—breast cancer	3.1e-05	0.000814	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—HGF—breast cancer	3.1e-05	0.000814	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CSF2—breast cancer	3.06e-05	0.000805	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTA3—breast cancer	2.99e-05	0.000786	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMMR—breast cancer	2.99e-05	0.000786	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCC1—breast cancer	2.99e-05	0.000786	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PPARGC1B—breast cancer	2.89e-05	0.000761	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—HMOX1—breast cancer	2.88e-05	0.000756	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.82e-05	0.000741	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.82e-05	0.000741	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCB1—breast cancer	2.76e-05	0.000726	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SRC—breast cancer	2.74e-05	0.00072	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CA9—breast cancer	2.73e-05	0.000719	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTA4—breast cancer	2.73e-05	0.000719	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.7e-05	0.00071	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.67e-05	0.000703	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	2.67e-05	0.000701	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTA2—breast cancer	2.66e-05	0.0007	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX2—breast cancer	2.66e-05	0.0007	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MMP1—breast cancer	2.63e-05	0.000692	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX4—breast cancer	2.63e-05	0.000692	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SULT1A1—breast cancer	2.63e-05	0.000692	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLAU—breast cancer	2.58e-05	0.000679	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CDK2—breast cancer	2.58e-05	0.000679	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTA1—breast cancer	2.57e-05	0.000676	CbGpPWpGaD
Cefotetan—ALB—Metabolism—IDH1—breast cancer	2.57e-05	0.000676	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NAT2—breast cancer	2.54e-05	0.000668	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CAV1—breast cancer	2.52e-05	0.000664	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	2.52e-05	0.000663	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	2.45e-05	0.000644	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—FN1—breast cancer	2.4e-05	0.000632	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS2—breast cancer	2.37e-05	0.000624	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CG—breast cancer	2.3e-05	0.000604	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.3e-05	0.000604	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—EGF—breast cancer	2.27e-05	0.000597	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MED12—breast cancer	2.23e-05	0.000586	CbGpPWpGaD
Cefotetan—ALB—Metabolism—DPYD—breast cancer	2.23e-05	0.000586	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALDOA—breast cancer	2.19e-05	0.000577	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NCOA3—breast cancer	2.13e-05	0.00056	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC2A2—breast cancer	2.11e-05	0.000556	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IGF1—breast cancer	2.1e-05	0.000553	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—AKT2—breast cancer	2.1e-05	0.000553	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.09e-05	0.00055	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	2.08e-05	0.000548	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCG2—breast cancer	2.07e-05	0.000545	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CPT1A—breast cancer	2.07e-05	0.000545	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTR—breast cancer	2.07e-05	0.000545	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HPGDS—breast cancer	2.03e-05	0.000534	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CD—breast cancer	2.02e-05	0.000531	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HBA1—breast cancer	2.02e-05	0.000531	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SERPINE1—breast cancer	2e-05	0.000526	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTT1—breast cancer	1.97e-05	0.000518	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ACHE—breast cancer	1.97e-05	0.000518	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NOS3—breast cancer	1.91e-05	0.000502	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP17A1—breast cancer	1.87e-05	0.00049	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ENO1—breast cancer	1.85e-05	0.000486	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PTGS1—breast cancer	1.85e-05	0.000486	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.84e-05	0.000484	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP2D6—breast cancer	1.81e-05	0.000476	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—RAF1—breast cancer	1.8e-05	0.000474	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NCOA2—breast cancer	1.78e-05	0.000467	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CB—breast cancer	1.76e-05	0.000463	CbGpPWpGaD
Cefotetan—ALB—Metabolism—FASN—breast cancer	1.72e-05	0.000453	CbGpPWpGaD
Cefotetan—ALB—Metabolism—BCHE—breast cancer	1.72e-05	0.000451	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	1.7e-05	0.000447	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC5A5—breast cancer	1.7e-05	0.000446	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC2A1—breast cancer	1.64e-05	0.000431	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NQO1—breast cancer	1.64e-05	0.000431	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IL2—breast cancer	1.62e-05	0.000425	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.6e-05	0.000422	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP3A4—breast cancer	1.6e-05	0.00042	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.59e-05	0.000418	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP1B1—breast cancer	1.57e-05	0.000413	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	1.56e-05	0.000411	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HSP90AA1—breast cancer	1.54e-05	0.000405	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NCOA1—breast cancer	1.5e-05	0.000394	CbGpPWpGaD
Cefotetan—ALB—Metabolism—STK11—breast cancer	1.48e-05	0.000388	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP19A1—breast cancer	1.48e-05	0.000388	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SRC—breast cancer	1.41e-05	0.000371	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.39e-05	0.000364	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VEGFA—breast cancer	1.37e-05	0.000361	CbGpPWpGaD
Cefotetan—ALB—Metabolism—COMT—breast cancer	1.37e-05	0.000361	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTP1—breast cancer	1.37e-05	0.000359	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMOX1—breast cancer	1.35e-05	0.000354	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ITPR1—breast cancer	1.34e-05	0.000353	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MAPK3—breast cancer	1.3e-05	0.000342	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCB1—breast cancer	1.29e-05	0.00034	CbGpPWpGaD
Cefotetan—ALB—Metabolism—TYMS—breast cancer	1.27e-05	0.000334	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TGFB1—breast cancer	1.26e-05	0.000332	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTM1—breast cancer	1.26e-05	0.00033	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PLA2G4A—breast cancer	1.26e-05	0.00033	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NCOR1—breast cancer	1.26e-05	0.00033	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX1—breast cancer	1.2e-05	0.000316	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP1A1—breast cancer	1.19e-05	0.000313	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ERCC2—breast cancer	1.18e-05	0.00031	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—KRAS—breast cancer	1.17e-05	0.000307	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTHFR—breast cancer	1.11e-05	0.000292	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CA—breast cancer	1.07e-05	0.000282	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TP53—breast cancer	1.04e-05	0.000273	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CAV1—breast cancer	1.02e-05	0.000269	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—HRAS—breast cancer	9.93e-06	0.000261	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.77e-06	0.000257	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CG—breast cancer	9.32e-06	0.000245	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—AKT1—breast cancer	8.77e-06	0.000231	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CD—breast cancer	8.19e-06	0.000215	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NOS3—breast cancer	7.74e-06	0.000203	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CB—breast cancer	7.14e-06	0.000188	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PTGS2—breast cancer	7.08e-06	0.000186	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PTEN—breast cancer	6.17e-06	0.000162	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CA—breast cancer	4.35e-06	0.000114	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AKT1—breast cancer	3.56e-06	9.35e-05	CbGpPWpGaD
